Guillain Barre May Be a Tragic, Though Rare, Side Effect. Employers Should Promote Covid Vaccines Anyway

This is a preview. View original post on this site

Guillain Barre syndrome is a rare but serious neurological disease that requires hospitalization in almost all victims and has no known cure. With such a description, employers and people, in general, might be a little cautious about proceeding with the Johnson & Johnson Covid vaccine. The U.S. Food and Drug Administration announced on July 12 that Guillain Barre syndrome is a rare side effect of this vaccine.

It sounds scary, and it might make you think about not encouraging your employees to receive their vaccine, but take a step back. Don’t panic. Here’s what employers need to know.

To keep reading, click here: Guillain

Read Complete Article


Subscribe to Recruiting Headlines

* indicates required


»Need an ATS? Try JazzHR

»Free Rejection Email Templates

»Text Recruiting Software

»RecTech Live Webcasts

»HR Podcast Directory

»Recruiting Newsletters

»HR Tech News

»Freelance HR Jobs

»Diversity Hiring News

»Recruiter Ebooks